Metabolic Disorders Completed Phase 3 Trials for Losartan (DB00678)
Also known as: Metabolic Disorder / Metabolic disorder, unspecified / Metabolic disorder NOS / Generalized metabolic disorder (disorder) / Unspecified disorder of metabolism / Metabolic disease (disorder) / Metabolic Diseases
Indication | Status | Phase |
---|---|---|
DBCOND0035995 (Metabolic Disorders) | Completed | 3 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00546052 | A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331) | Treatment |